EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Isa-Kd in relapsed/refractory multiple myeloma (RRMM): beyond controlled clinical trials – a detailed real-world analysis

Isabel García-Cabrera, Esther Clavero, Magdalena Alcalá, Ricarda García-Sánchez, María Casanova, Maria C. Galán, Miguel A. Álvarez, Sebastián Garzón, Rocío Fe, María Jiménez

Annals of Hematology · 21.11.2026

DOI: 10.1007/s00277-026-07369-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 21.11.2026. Verfasst von Isabel García-Cabrera und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

García-Cabrera, I., Clavero, E., Alcalá, M., García-Sánchez, R., Casanova, M., Galán, M. C., Álvarez, M. A., Garzón, S., Fe, R., & Jiménez, M. (2026). Isa-Kd in relapsed/refractory multiple myeloma (RRMM): beyond controlled clinical trials – a detailed real-world analysis. Annals of Hematology. https://doi.org/10.1007/s00277-026-07369-3

Vancouver

García-Cabrera I, Clavero E, Alcalá M, García-Sánchez R, Casanova M, Galán MC, et al. Isa-Kd in relapsed/refractory multiple myeloma (RRMM): beyond controlled clinical trials – a detailed real-world analysis. Annals of Hematology. 2026. doi:10.1007/s00277-026-07369-3

BibTeX
@article{GarcaCabrera2026,
  author = {García-Cabrera, Isabel and Clavero, Esther and Alcalá, Magdalena and García-Sánchez, Ricarda and Casanova, María and Galán, Maria C. and Álvarez, Miguel A. and Garzón, Sebastián and Fe, Rocío and Jiménez, María},
  title = {Isa-Kd in relapsed/refractory multiple myeloma (RRMM): beyond controlled clinical trials – a detailed real-world analysis},
  journal = {Annals of Hematology},
  year = {2026},
  doi = {10.1007/s00277-026-07369-3}
}
Kostenlos starten →